SECreport

Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.

AN2 Therapeutics, Inc.  (ANTX) 
US:NYSE Investor Relations: ir.antheminc.com